170 related articles for article (PubMed ID: 30323284)
1. Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers.
Watt JM; Thomas MP; Potter BVL
Sci Rep; 2018 Oct; 8(1):15268. PubMed ID: 30323284
[TBL] [Abstract][Full Text] [Related]
2. Cyclic ADP-ribose analogues containing the methylenebisphosphonate linkage: effect of pyrophosphate modifications on Ca2+ release activity.
Xu L; Walseth TF; Slama JT
J Med Chem; 2005 Jun; 48(12):4177-81. PubMed ID: 15943490
[TBL] [Abstract][Full Text] [Related]
3. Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".
Watt JM; Graeff R; Thomas MP; Potter BVL
Sci Rep; 2017 Nov; 7(1):16100. PubMed ID: 29170518
[TBL] [Abstract][Full Text] [Related]
4. First enzymatic synthesis of an N1-cyclised cADPR (cyclic-ADP ribose) analogue with a hypoxanthine partial structure: discovery of a membrane permeant cADPR agonist.
Wagner GK; Black S; Guse AH; Potter BV
Chem Commun (Camb); 2003 Aug; (15):1944-5. PubMed ID: 12932045
[TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.
Swarbrick JM; Graeff R; Zhang H; Thomas MP; Hao Q; Potter BV
J Med Chem; 2014 Oct; 57(20):8517-29. PubMed ID: 25226087
[TBL] [Abstract][Full Text] [Related]
6. Chemistry of cyclic ADP-ribose and its analogs.
Shuto S; Matsuda A
Curr Med Chem; 2004 Apr; 11(7):827-45. PubMed ID: 15078168
[TBL] [Abstract][Full Text] [Related]
7. Aberrant cyclization affords a C-6 modified cyclic adenosine 5'-diphosphoribose analogue with biological activity in Jurkat T cells.
Moreau C; Kirchberger T; Zhang B; Thomas MP; Weber K; Guse AH; Potter BV
J Med Chem; 2012 Feb; 55(4):1478-89. PubMed ID: 22248391
[TBL] [Abstract][Full Text] [Related]
8. Rapid synthetic route toward structurally modified derivatives of cyclic adenosine 5'-diphosphate ribose.
Wagner GK; Guse AH; Potter BV
J Org Chem; 2005 Jun; 70(12):4810-9. PubMed ID: 15932322
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of stable and cell-type selective analogues of cyclic ADP-ribose, a Ca(2+)-mobilizing second messenger. Structure--activity relationship of the N1-ribose moiety.
Kudoh T; Fukuoka M; Ichikawa S; Murayama T; Ogawa Y; Hashii M; Higashida H; Kunerth S; Weber K; Guse AH; Potter BV; Matsuda A; Shuto S
J Am Chem Soc; 2005 Jun; 127(24):8846-55. PubMed ID: 15954793
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis of a cyclic adenosine 5'-diphosphate ribose receptor agonist.
Swarbrick JM; Potter BV
J Org Chem; 2012 May; 77(9):4191-7. PubMed ID: 22283398
[TBL] [Abstract][Full Text] [Related]
11. Cyclic ADP-Carbocyclic-Ribose and -4-Thioribose, as Stable Mimics of Cyclic ADP-Ribose, a Ca
Shuto S
Chem Pharm Bull (Tokyo); 2018; 66(2):155-161. PubMed ID: 29386466
[TBL] [Abstract][Full Text] [Related]
12. Aplysia californica mediated cyclisation of novel 3'-modified NAD+ analogues: a role for hydrogen bonding in the recognition of cyclic adenosine 5'-diphosphate ribose.
Mort CJ; Migaud ME; Galione A; Potter BV
Bioorg Med Chem; 2004 Jan; 12(2):475-87. PubMed ID: 14723966
[TBL] [Abstract][Full Text] [Related]
13. 2'-deoxy cyclic adenosine 5'-diphosphate ribose derivatives: importance of the 2'-hydroxyl motif for the antagonistic activity of 8-substituted cADPR derivatives.
Zhang B; Wagner GK; Weber K; Garnham C; Morgan AJ; Galione A; Guse AH; Potter BV
J Med Chem; 2008 Mar; 51(6):1623-36. PubMed ID: 18303825
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of cyclic adenosine 5'-diphosphate ribose analogues: a C2'endo/syn "southern" ribose conformation underlies activity at the sea urchin cADPR receptor.
Moreau C; Ashamu GA; Bailey VC; Galione A; Guse AH; Potter BV
Org Biomol Chem; 2011 Jan; 9(1):278-90. PubMed ID: 20976353
[TBL] [Abstract][Full Text] [Related]
15. CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.
Moreau C; Liu Q; Graeff R; Wagner GK; Thomas MP; Swarbrick JM; Shuto S; Lee HC; Hao Q; Potter BV
PLoS One; 2013; 8(6):e66247. PubMed ID: 23840430
[TBL] [Abstract][Full Text] [Related]
16. Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.
Kirchberger T; Wagner G; Xu J; Cordiglieri C; Wang P; Gasser A; Fliegert R; Bruhn S; Flügel A; Lund FE; Zhang LH; Potter BV; Guse AH
Br J Pharmacol; 2006 Oct; 149(4):337-44. PubMed ID: 16967053
[TBL] [Abstract][Full Text] [Related]
17. ADP-ribosyl cyclase: an enzyme that cyclizes NAD+ into a calcium-mobilizing metabolite.
Lee HC; Aarhus R
Cell Regul; 1991 Mar; 2(3):203-9. PubMed ID: 1830494
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a new N-9 ribityl analogue of cyclic inosine diphosphate ribose (cIDPR) as a mimic of cyclic ADP ribose (cADPR).
Oliviero G; Amato J; Varra M; Piccialli G; Mayol L
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):735-8. PubMed ID: 16248026
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of intermediates along the cyclization pathway of Aplysia ADP-ribosyl cyclase.
Kotaka M; Graeff R; Chen Z; Zhang LH; Lee HC; Hao Q
J Mol Biol; 2012 Jan; 415(3):514-26. PubMed ID: 22138343
[TBL] [Abstract][Full Text] [Related]
20. Chemoenzymatic synthesis of 7-deaza cyclic adenosine 5'-diphosphate ribose analogues, membrane-permeant modulators of intracellular calcium release.
Zhang B; Bailey VC; Potter BV
J Org Chem; 2008 Mar; 73(5):1693-703. PubMed ID: 18229937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
